Recurrent ovarian cancer treatment practices

Personalising medicine and the panel’s predictions for oncotechnologies (2/4)

Advancing multidisciplinary cancer management (1/4)

Role, relevance and participation of all stakeholders in oncology (3/4)

Concluding remarks (4/4)

Bench, bedside, ‘bytes’ and back: a virtuous cycle of knowledge (1/5)

Personalised medicine: how the 2011 Multidisciplinary Cancer Congress will mark important milestones in getting the right treatment to the right patient at the right time (2/5)

Serendipity of cancer science & programme highlights (3/5)

Oncopolicy: tackling the inequalities in cancer research and care across Europe (4/5)

Multidisciplinary mass gathering and celebration of European basic, translational and clinical studies (5/5)

Treatment of elderly gynaecological cancer patients

New system of staging for gynaecological cancers